ATE238274T1 - Naphthalin derivate - Google Patents

Naphthalin derivate

Info

Publication number
ATE238274T1
ATE238274T1 AT98959166T AT98959166T ATE238274T1 AT E238274 T1 ATE238274 T1 AT E238274T1 AT 98959166 T AT98959166 T AT 98959166T AT 98959166 T AT98959166 T AT 98959166T AT E238274 T1 ATE238274 T1 AT E238274T1
Authority
AT
Austria
Prior art keywords
hydroxy
halogen
protected
amino
carboxy
Prior art date
Application number
AT98959166T
Other languages
English (en)
Inventor
Kouji Hattori
Hiromichi Itani
Akira Tanaka
Toshifumi Shiraga
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE238274T1 publication Critical patent/ATE238274T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AT98959166T 1997-12-22 1998-12-11 Naphthalin derivate ATE238274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP1090A AUPP109097A0 (en) 1997-12-22 1997-12-22 Napthalene derivatives
PCT/JP1998/005603 WO1999032435A1 (en) 1997-12-22 1998-12-11 Naphthalene derivatives

Publications (1)

Publication Number Publication Date
ATE238274T1 true ATE238274T1 (de) 2003-05-15

Family

ID=3805372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959166T ATE238274T1 (de) 1997-12-22 1998-12-11 Naphthalin derivate

Country Status (8)

Country Link
US (1) US6303649B1 (de)
EP (1) EP1042277B1 (de)
JP (1) JP2001526257A (de)
AT (1) ATE238274T1 (de)
AU (1) AUPP109097A0 (de)
DE (1) DE69813886T2 (de)
ES (1) ES2198778T3 (de)
WO (1) WO1999032435A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335459B1 (en) 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
US8575175B2 (en) 2008-07-23 2013-11-05 Toray Industries, Inc. Therapeutic agent for chronic renal failure
KR20120139723A (ko) * 2010-02-01 2012-12-27 더 호스피탈 포 식 칠드런 재발협착증의 치료 및 예방을 위한 원격 허혈 처치
CA2795053A1 (en) 2010-03-31 2011-10-06 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction
SG10201908576VA (en) 2010-04-08 2019-10-30 Hospital For Sick Children Use of remote ischemic conditioning for traumatic injury
WO2014199239A2 (en) 2013-03-15 2014-12-18 The Hospital For Sick Children Methods relating to the use of remote ischemic conditioning
WO2014140832A2 (en) 2013-03-15 2014-09-18 The Hospital For Sick Children Treatment of erectile dysfunction using remote ischemic conditioning
CA2942614A1 (en) 2013-03-15 2014-10-16 The Hospital For Sick Children Methods for modulating autophagy using remote ischemic conditioning

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046714C (zh) 1993-12-20 1999-11-24 藤泽药品工业株式会社 二芳基噁唑衍生物及其制法、应用和药物组合物
TW282456B (de) * 1994-03-10 1996-08-01 Fujisawa Yakusin Kogyo Kk
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism

Also Published As

Publication number Publication date
DE69813886T2 (de) 2004-01-08
EP1042277A1 (de) 2000-10-11
DE69813886D1 (de) 2003-05-28
EP1042277B1 (de) 2003-04-23
JP2001526257A (ja) 2001-12-18
US6303649B1 (en) 2001-10-16
WO1999032435A1 (en) 1999-07-01
ES2198778T3 (es) 2004-02-01
AUPP109097A0 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
ES2160156T3 (es) Derivados de naftaleno como agonistas de la prostaglandina i2.
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
ES2196396T3 (es) Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
ATE194335T1 (de) 4,5-diaryloxazol-derivate
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
DE69428476D1 (de) Heterocyclische Verbindungen als Bradykinin Antagonisten
TR200100917T2 (tr) Aril ve heteroaril sübstitüentli heteroksiklik üreler kullanılarak RAF kinazın inhibe edilmesi
AP2001002241A0 (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents.
DE69930947D1 (de) Piperazin-4-phenyl-derivate als inhibitoren der wechselwirkung zwischen mdm2 und mdm2
NO20020725L (no) Celleadhesjonsinhibitorer
TR200103683T2 (tr) Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı
ATE232520T1 (de) Imidazolidin-4-on derivate verwendbar als antikrebsmittel
ATE325796T1 (de) Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
DE69718194D1 (de) Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate
PL351878A1 (en) Amino compound derivatives
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
NZ334954A (en) Substituted heterocycles as anti-tumor agents
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
DE60001586D1 (de) Diphenyl-piperidin derivate
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
DE69813886D1 (de) Naphthalin derivate
PT1098885E (pt) Compostos de imidazole e sua utilizacao como inibidores da desaminase de adenosina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties